3.06
price up icon6.25%   0.18
after-market Handel nachbörslich: 3.11 0.05 +1.63%
loading

MAIA Biotechnology Inc Aktie (MAIA) Neueste Nachrichten

pulisher
09:45 AM

MAIA Biotechnology Announces Late-Breaking Abstract of THIO-101 Updates Selected for Oral and Poster Presentation at the Society for Immunotherapy of Cancer (SITC) 39th Annual Meeting - StockTitan

09:45 AM
pulisher
Nov 04, 2024

Maia Biotechnology director Stan Smith buys shares worth $250,999 - Investing.com

Nov 04, 2024
pulisher
Nov 04, 2024

Maia Biotechnology director Stan Smith buys shares worth $250,999 By Investing.com - Investing.com Australia

Nov 04, 2024
pulisher
Nov 04, 2024

Insider Buying: MAIA Biotechnology, Inc. (NYSEAMERICAN:MAIA) Director Acquires 22,133 Shares of Stock - MarketBeat

Nov 04, 2024
pulisher
Nov 04, 2024

Director Cristian Luput Acquires 22,133 Shares of MAIA Biotechno - GuruFocus.com

Nov 04, 2024
pulisher
Nov 04, 2024

Director Ramiro Guerrero Acquires 88,534 Shares of MAIA Biotechn - GuruFocus.com

Nov 04, 2024
pulisher
Nov 04, 2024

Maia Biotechnology director Steven Chaouki buys $55,553 in shares - Investing.com

Nov 04, 2024
pulisher
Nov 04, 2024

Maia Biotechnology director Luput acquires shares worth $55,553 By Investing.com - Investing.com Nigeria

Nov 04, 2024
pulisher
Nov 04, 2024

Maia Biotechnology director Luput acquires shares worth $55,553 - Investing.com

Nov 04, 2024
pulisher
Oct 29, 2024

Cosmo Metals Secures $500,000 for Strategic Expansion - MSN

Oct 29, 2024
pulisher
Oct 29, 2024

Antipa Minerals Expands Share Offering on ASX - MSN

Oct 29, 2024
pulisher
Oct 29, 2024

WAM Alternative Assets Expands ASX Securities Offering - MSN

Oct 29, 2024
pulisher
Oct 29, 2024

Argent BioPharma Issues New Shares Amidst Strategic Growth - MSN

Oct 29, 2024
pulisher
Oct 28, 2024

MAIA Biotechnology Announces $2.44 Million Private Placement - StockTitan

Oct 28, 2024
pulisher
Oct 25, 2024

MAIA Biotechnology (NYSEAMERICAN:MAIA) Stock Price Down 3.4%Here's What Happened - MarketBeat

Oct 25, 2024
pulisher
Oct 25, 2024

MAIA Biotechnology (NYSEAMERICAN:MAIA) Shares Down 3.4% – Time to Sell? - Defense World

Oct 25, 2024
pulisher
Oct 23, 2024

Alterity Therapeutics Prepares for 2024 Annual General Meeting - MSN

Oct 23, 2024
pulisher
Oct 22, 2024

Li Bang International announces pricing of initial public offering - MSN

Oct 22, 2024
pulisher
Oct 15, 2024

MAIA Biotechnology Announces Poster Presentation of Novel THIO Prodrugs at ENA 2024 Symposium on Molecular Targets and Cancer Therapeutics - BioSpace

Oct 15, 2024
pulisher
Oct 03, 2024

MAIA Biotechnology (NYSEAMERICAN:MAIA) Trading Down 1.1% - MarketBeat

Oct 03, 2024
pulisher
Sep 27, 2024

BioAge, BKV shares end their first trading day flat after earlier gains - MSN

Sep 27, 2024
pulisher
Sep 27, 2024

Weight-loss drug developer BioAge Labs aims to raise $198M from U.S. IPO - MSN

Sep 27, 2024
pulisher
Sep 21, 2024

Healthcare Stock Performance - Yahoo Finance

Sep 21, 2024
pulisher
Sep 18, 2024

Short Interest in Biomea Fusion, Inc. (NASDAQ:BMEA) Expands By 7.8% - Defense World

Sep 18, 2024
pulisher
Sep 18, 2024

Daiwa Securities Group Inc. Invests $82,000 in Haemonetics Co. (NYSE:HAE) - Defense World

Sep 18, 2024
pulisher
Sep 18, 2024

Promising signs for MAIA’s telomere-targeting treatment - The Pharma Letter

Sep 18, 2024
pulisher
Sep 18, 2024

Mayne Pharma Group (OTCMKTS:MAYNF) Shares Down 8% - Defense World

Sep 18, 2024
pulisher
Sep 13, 2024

THIO Combo Yields Survival Benefit in Advanced NSCLC - AJMC.com Managed Markets Network

Sep 13, 2024
pulisher
Sep 13, 2024

Bicara Leads Trio of US Biotech IPOs Raising $703 Million - Bloomberg

Sep 13, 2024
pulisher
Sep 12, 2024

INVESTOR DEADLINE APPROACHING: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of CAE - PR Newswire

Sep 12, 2024
pulisher
Sep 12, 2024

Summit Therapeutics jumps 4%, raises $235M - MSN

Sep 12, 2024
pulisher
Sep 11, 2024

MAIA Biotechnology Reports Promising Interim Results in Lung Cancer Treatment Study - Vancity Buzz

Sep 11, 2024
pulisher
Sep 11, 2024

MAIA Biotechnology Inc’s latest rating changes from various analysts - Knox Daily

Sep 11, 2024
pulisher
Sep 11, 2024

MAIA reports survival benefit in advanced lung cancer trial - Investing.com

Sep 11, 2024
pulisher
Sep 11, 2024

MAIA Biotech releases Phase II results for THIO - The Pharma Letter

Sep 11, 2024
pulisher
Sep 11, 2024

MAIA reports survival benefit in advanced lung cancer trial By Investing.com - Investing.com Australia

Sep 11, 2024
pulisher
Sep 10, 2024

MAIA Biotechnology Advances with Clinical Trials and Partnerships - TipRanks

Sep 10, 2024
pulisher
Sep 10, 2024

MAIA Biotechnology Announces Positive Survival Updates in Phase 2 Study of THIO in Non-Small Cell Lung Cancer - StockTitan

Sep 10, 2024
pulisher
Sep 04, 2024

MAIA Biotechnology, Inc. to Present New Phase 2 Clinical Trial Data at the H.C. Wainwright 26th Annual Global Investment Conference - Marketscreener.com

Sep 04, 2024
pulisher
Sep 04, 2024

MAIA Biotechnology to Present New Phase 2 Clinical Trial Data at the H.C. Wainwright 26th Annual Global Investment Conference - StockTitan

Sep 04, 2024
pulisher
Sep 04, 2024

MAIA Biotechnology (NYSEAMERICAN:MAIA) Stock Price Down 3.9% - MarketBeat

Sep 04, 2024
pulisher
Sep 04, 2024

MAIA Biotechnology (NYSEAMERICAN:MAIA) Shares Down 3.9% - Defense World

Sep 04, 2024
pulisher
Sep 02, 2024

MAIA Biotechnology Inc [MAIA] Investment Guide: What You Need to Know - Knox Daily

Sep 02, 2024
pulisher
Sep 02, 2024

MAIA Biotechnology, Inc. (NYSEAMERICAN:MAIA) Short Interest Down 13.9% in August - MarketBeat

Sep 02, 2024
pulisher
Aug 20, 2024

Lazertinib With Amivantamab Approved by FDA for Use in NSCLC - AJMC.com Managed Markets Network

Aug 20, 2024
pulisher
Aug 10, 2024

Mather Group LLC. Increases Stock Position in MAIA Biotechnology, Inc. (NYSEAMERICAN:MAIA) - Defense World

Aug 10, 2024
pulisher
Aug 09, 2024

MAIA Biotechnology, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2024 - Marketscreener.com

Aug 09, 2024
pulisher
Aug 08, 2024

32,487 Shares in MAIA Biotechnology, Inc. (NYSEAMERICAN:MAIA) Acquired by Virtu Financial LLC - Defense World

Aug 08, 2024
pulisher
Jul 26, 2024

Mirum Pharma gains amid report of approach from Swedish Orphan Biovitrum - MSN

Jul 26, 2024
pulisher
Jul 26, 2024

Officials Provide Update on Phase 2 Trial of THIO Plus Cemiplimab in NSCLC - DocWire News

Jul 26, 2024
pulisher
Jul 24, 2024

Investing in MAIA Biotechnology Inc (MAIA): What You Must Know - Knox Daily

Jul 24, 2024
pulisher
Jul 23, 2024

Evaluating MAIA’s financial ratios for a profitable investment - US Post News

Jul 23, 2024
pulisher
Jul 23, 2024

MAIA Biotechnology (MAIA) is one of the earliest pioneers of telomere targeting as a therapeutic strategy - openPR

Jul 23, 2024
pulisher
Jul 23, 2024

MAIA Biotechnology's Lung Cancer Drug Shows Promising Long-Term Benefits In Advanced Patients - Benzinga

Jul 23, 2024
pulisher
Jul 23, 2024

Why SAP Shares Are Trading Higher; Here Are 20 Stocks Moving Premarket - Benzinga

Jul 23, 2024
pulisher
Jul 23, 2024

MAIA Biotechnology Announces New Updates from Phase 2 Trial of Novel Cancer Treatment Agent - Business Wire

Jul 23, 2024
pulisher
Jul 20, 2024

GeoVax Labs (NASDAQ:GOVXW) Shares Up 3.3% - Defense World

Jul 20, 2024
pulisher
Jul 20, 2024

MAIA Biotechnology (NYSEAMERICAN:MAIA) Trading Up 6.1% - MarketBeat

Jul 20, 2024
pulisher
Jul 20, 2024

Signature Bank (NASDAQ:SBNYP) Trading Down 14.3% - Defense World

Jul 20, 2024
pulisher
Jul 20, 2024

MAIA Biotechnology (NYSEAMERICAN:MAIA) Trading 6.1% Higher - Defense World

Jul 20, 2024
pulisher
Jul 16, 2024

Cazoo racked up debts of over £260m as it collapsed into administration - Yahoo Finance UK

Jul 16, 2024
$77.28
price up icon 2.02%
$20.39
price up icon 2.15%
$382.77
price up icon 1.58%
$53.29
price down icon 0.47%
$208.03
price up icon 0.38%
$110.97
price up icon 1.84%
Kapitalisierung:     |  Volumen (24h):